Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial
Vogelzang, Nicholas J, Beer, Tomasz M, Gerritsen, Winald, Oudard, Stéphane, Wiechno, Pawel, Kukielka-Budny, Bozena, Samal, Vladimir, Hajek, Jaroslav, Feyerabend, Susan, Khoo, Vincent, Stenzl, Arnulf, Csöszi, Tibor, Filipovic, Zoran, Goncalves, Frederico, Prokhorov, Alexander, Cheung, Eric, Hussain, Arif, Sousa, Nuno, Bahl, Amit, Hussain, Syed, Fricke, Harald, Kadlecova, Pavla, Scheiner, Tomas, Korolkiewicz, Roman P, Bartunkova, Jirina, Spisek, Radek
Published in JAMA oncology (01.04.2022)
Published in JAMA oncology (01.04.2022)
Get more information
Journal Article
Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry
Geiges, Götz, Harms, Thomas, Rodemer, Gerald, Eckert, Ralf, König, Frank, Eichenauer, Rolf, Schroder, Jörg
Published in BMC urology (16.12.2015)
Published in BMC urology (16.12.2015)
Get full text
Journal Article